Skip to main content
SpringerLink
Log in

Comparison of two classifications of metabolic syndrome in the pediatric population and the impact of cholesterol

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: To establish the rate of agreement in predicting metabolic syndrome (MS) in different pediatric classifications using percentiles or fixed cut-offs, as well as exploring the influence of cholesterol. Subjects and methods: Cross-sectional study in a tertiary care center. Nine hundred and twenty-three obese children and adolescents were evaluated for metabolic characteristics, cholesterol levels, the agreement rate and prevalence of MS across age subgroups with pediatric National Cholesterol Education Program/Adult Treatment Panel III (NCEP-ATP III) and International Diabetes Federation (IDF) classifications. Results: The overall prevalence of MS was 36.2% and 56.7% with NCEP-ATP III and IDF. The overall concordance was fair (k: 0.269), with substantial values observed only in children older than 10 (k: 0.708) and 16 yr (0.694). Concordant subjects for both classifications, ≤6 yr, had higher triglycerides, blood pressure (p<0.05) and lower HDL-cholesterol (p<0.0001), with respect to those found to be discordant. Concordant subjects ranging 6–10 yr had all parameters higher than those discordant for IDF (p<0.01) and insulin resistance (p<0.05) than those discordant for NCEP-ATP III. Concordant subjects ≥10 yr presented more altered parameters than those included only in NCEP-ATP III (p<0.05). Overt glucose alterations were uncommon (7.4%; confidence interval 95% 0.1–14.9%), although glucose was modestly higher in MS subjects (p<0.01). Total and LDL-cholesterol was lower in subjects with MS than in those without (p<0.05), and in concordant rather than discordant subjects (p<0.05). Conclusions: Classifications of MS do not identify the same pediatric population. Subjects who satisfied any classification were the most compromised. Lipid alterations were precocious in the youngest. Obese youths with MS presented lower total and LDL-cholesterol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lobstein T, Frelut ML. Prevalence of overweight among children in Europe. Obes Rev 2003, 4: 195–200.

    Article  PubMed  Google Scholar 

  2. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002, 46: 802–10.

    Article  Google Scholar 

  3. Cruz ML, Weigensberg MJ, Huang TT-K, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004, 89: 108–13.

    Article  PubMed  Google Scholar 

  4. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003, 57: 821–7.

    Article  Google Scholar 

  5. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004, 110: 2494–7.

    Article  PubMed  Google Scholar 

  6. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004, 350: 2362–74.

    Article  PubMed  Google Scholar 

  7. Zimmet P, Alberti G, Kaufman F, et al. International Diabetes Federation Task Force on Epidemiology and Prevention of Diabetes. The metabolic syndrome in children and adolescents. Lancet 2007, 369: 2059–61.

    Article  PubMed  Google Scholar 

  8. Caranti DA, Lazzer S, Damaso AR, et al. Prevalence and risk factors of metabolic syndrome in Brazilian and Italian obese adolescents: a comparison study. Int J Clin Pract 2008, 62: 1526–32.

    Article  PubMed  Google Scholar 

  9. Seo SJ, Lee HY, Lee SW. The prevalence of the metabolic syndrome in Korean children and adolescents: comparisons of the criteria of Cook et al., Cruz and Goran, and Ferranti et al. Yonsei Medical J 2008, 49: 563–72.

    Article  Google Scholar 

  10. Di Bonito P, Forziato C, Sanguigno E, et al. Prevalence of the metabolic syndrome using ATP-derived definitions and its relation to insulin-resistance in a cohort of Italian outpatient children. J Endocrinol Invest 2010, 33: 806–9.

    PubMed  Google Scholar 

  11. Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009, 119: 628–47.

    Article  PubMed  Google Scholar 

  12. Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 2005, 90: 10–4.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Sen Y, Kandemir N, Alikasifoglu A, Gonc N, Ozon A. Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity. Eur J Pediatr 2008, 167: 1183–9.

    Article  PubMed  Google Scholar 

  14. Cacciari E, Milani S, Balsamo A, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006, 29: 581–93.

    PubMed  Google Scholar 

  15. Prodam F, Trovato L, Demarchi I, et al. Unacylated, acylated ghrelin and obestatin levels are differently inhibited by oral glucose load in pediatric obesity: association with insulin sensitivity and metabolic alterations. e-SPEN Eur J Clin Nutr Metab 2011, 6: e109–15.

    Article  Google Scholar 

  16. McCarthy HD, Jarrett KV, Crawley HF. The development of waist circumference percentiles in British children aged 5.0 ± 16.9 y. Eur J Clin Nutr 2001, 55: 902–7.

    Article  PubMed  Google Scholar 

  17. Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics 2008, 122: 198.

    Article  PubMed  Google Scholar 

  18. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114: 555–76.

    Article  Google Scholar 

  19. Bokor S, Frelut ML, Vania A, et al. Prevalence of metabolic syndrome in European obese children. Int J Pediatr Obes 2008, 3(Suppl 2): 3–8.

    Article  PubMed  Google Scholar 

  20. Lafortuna CL, Adorni F, Agosti F, et al. Prevalence of the metabolic syndrome among extremely obese adolescents in Italy and Germany. Diabetes Res Clin Pract 2010, 1: 14–21.

    Article  Google Scholar 

  21. Bustos P, Saez K, Gleisner A, Ulloa N, Calvo C, Asenjo S. Metabolic syndrome in obese adolescents. Pediatr Diabetes 2010, 11: 55–60.

    Article  PubMed  Google Scholar 

  22. Tzoulaki I, Sovio U, Pillas D, et al. Relation of immediate postnatal growth with obesity and related metabolic risk factors in adulthood: the northern Finland birth cohort 1966 study. Am J Epidemiol 2010, 171: 989–98.

    Article  PubMed  Google Scholar 

  23. Kashyap S, Belfort R, Gastaldelli A, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003, 52: 2461–74.

    Article  PubMed  Google Scholar 

  24. Reinehr T, de Sousa G, Toschke AM, Andler W. Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child 2007, 92: 1067–72.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Kleber M, de Sousa G, Papcke S, Reinehr T. Risk factors for impaired glucose tolerance in obese children and adolescents. World J Diabetes 2010, 1: 129–34.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Mayor S. Nearly 23,000 people in England aged under 18 have diabetes, survey shows. BMJ 2010, 340: c980.

    Article  PubMed  Google Scholar 

  27. Saad R, Gungor N, Arslanian S. Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates. Pediatr Diabetes 2005, 6: 95–9.

    Article  PubMed  Google Scholar 

  28. Tfayli H, Arslanian S. Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon. Arq Bras Endocrinol Metab 2009, 53: 165–74.

    Article  Google Scholar 

  29. Preiss D, Sattar N. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clin Endocrinol (Oxf) 2009, 70: 815–28.

    Article  Google Scholar 

  30. Simonen P, Gylling H, Howard AN, Miettinen TA. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 2000, 72: 82–8.

    PubMed  Google Scholar 

  31. Briand F, Thiéblemont Q, Muzotte E, Sulpice T. High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivo macrophage-to-feces reverse cholesterol transport in hamsters. J Nutr 2012, 142: 704–9.

    Article  PubMed  Google Scholar 

  32. Yang ZH, Miyahara H, Takeo J, Katayama M. Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice. Diabetol Metab Syndr 2012, 4: 32.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Alsaleh A, Frost GS, Griffin BA, et al; RISCK Study investigators. PPARγ2 gene Pro 12Ala and PPARα gene Leu 162Val single nucleotide polymorphisms interact with dietary intake of fat in determination of plasma lipid concentrations. J Nutrigenet Nutrigenomics 2011, 4: 354–66.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. SCDU of Pediatrics, Department of Health Sciences, University of Piemonte Orientale “Amedeo Avogadro”, via Solaroli 17, 28100, Novara, Italy

    F. Prodam MD, PhD, R. Ricotti, G. Genoni, S. Parlamento, A. Petri, C. Balossini, S. Savastio, G. Bona & S. Bellone

  2. Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale “A. Avogadro”, Novara, Italy

    F. Prodam MD, PhD & S. Bellone

  3. Interdisciplinary Centre for the Study of Obesity (ICSO), Università del Piemonte Orientale “A. Avogadro”, Novara, Italy

    F. Prodam MD, PhD, A. Petri, G. Bona & S. Bellone

Authors
  1. F. Prodam MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Ricotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Genoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Parlamento
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Petri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Balossini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Savastio
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Bona
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S. Bellone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Prodam MD, PhD.

Additional information

G.B. and S.B. last co-authorship.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prodam, F., Ricotti, R., Genoni, G. et al. Comparison of two classifications of metabolic syndrome in the pediatric population and the impact of cholesterol. J Endocrinol Invest 36, 466–473 (2013). https://doi.org/10.3275/8768

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/8768

Key-words

Search

Navigation